Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation

Thrombosis and Haemostasis

Volumn 85, Issue 4, 2001, Pages 694-701

  Eckly, A ^a   Gendrault, J L ^a   Hechler, B ^a   Cazenave, J P ^a   Gachet, C ^a  

^a INSERM   (France)

Author keywords

ADP receptors; Cytoskeleton; GTPases; Morphology; Platelet aggregation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ABCIXIMAB; ADENOSINE 2' PHOSPHATE 5' PHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; AR C 67085; BETA3 INTEGRIN; F ACTIN; GUANOSINE TRIPHOSPHATASE; INTEGRIN; PROTEIN CDC42; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN; THROMBIN; UNCLASSIFIED DRUG; ACTIN; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE PHOSPHATE; ANTITHROMBOCYTIC AGENT; AR C67085MX; DRUG DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; P2RY12 PROTEIN, HUMAN; PHOSPHOADENOSINE DIPHOSPHORIBOSE; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR;

ACTIN POLYMERIZATION; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; HUMAN; HUMAN CELL; LAMELLIPODIUM; MORPHOLOGY; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; SCANNING ELECTRON MICROSCOPY; SECRETORY GRANULE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; CALCIUM SIGNALING; CELL SIZE; COMPARATIVE STUDY; ELECTRON MICROSCOPY; METABOLISM; PHYSIOLOGY; THROMBOCYTE; ULTRASTRUCTURE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACTINS; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE MONOPHOSPHATE; BLOOD PLATELETS; CALCIUM SIGNALING; CDC42 GTP-BINDING PROTEIN; CELL SIZE; CYTOSKELETON; GTP-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, PURINERGIC P2; RHOA GTP-BINDING PROTEIN; THROMBIN;

EID: 0034745014     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615655     Document Type: Article

References (35)

1. ADP receptors on platelets
2. ADP receptors and clinical bleeding disorders
3. The P2Y1 receptor is necessary for ADP-induced platelet aggregation
4. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
5. Role of P2Y1 purinoceptor in ADP-induced platelet activation
6. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets
7. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets
8. Platelet shape change is mediated by both calcium-dependent and -independent signalling pathways
9. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor null mice
10. Defective platelet activation in Gαq-deficient mice
11. ADP induces partial aggregation without shape change and potentiates collagen induced aggregation in the absence of Gαq
12. Clopidogrel, a novel antiplatelet and antithrombotic agent
13. 2T purinoceptor antagonists: Definition of the role of ADP in arterial thrombosis
14. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
15. Molecular basis of ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
16. A key role of adenosine disphosphate in the irreversible platelet aggregation induced by the PAR1 activating peptide through the late activation of phosphoinositide 3-kinase
17. 33P) 2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production
18. Early changes in the substructure of the marginal bundle in human blood platelets responding to adenosine diphosphate
19. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets
20. Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets
21. Rho, rac, cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
22. Rho GTPases and the actin cytoskeleton
23. L'agrégation plaquettaire: Outil d'investigation clinique et d'étude pharmacologique. Méthodologie
24. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets
25. 2-induced platelet aggregation
26. Use of monoclonal antibodies to study the interaction between an integrin adhesion receptor, GP IIb-IIIa, and its physiological ligand, fibrinogen
27. Ultrastructural studies of platelets aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation
28. Protein of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and synthaxin 4
29. Regulated secretion in platelets: Identification of elements of the platelets exocytosis machinery
30. Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositides synthesis in permeabilized human platelets
31. Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor
32. IIbβ3
33. Bidirectional signaling between the cytoskeleton and integrins
34. Integrin αIIβ3-mediated translocation of CDC42Hs to the cytoskeleton in stimulated human platelets
35. The platelet cytoskeleton